ARID2 and squamous cell carcinoma: Finally, ARID2 mutations, which disrupt the SWI/SNF chromatin remodeling complex, and gain-of-function mutations in the RTK-RAS-MAPK pathway were enriched specifically in squamous cell carcinomas.